Skip to main content
. 2019 Jul 12;39(7):BSR20190708. doi: 10.1042/BSR20190708

Table 1. The association of PCAT1 polymorphisms and CRC risk.

SNP* Genotype PHWE Controls (%) CRC CRC vs CON Colon cancer vs CON Rectal cancer vs CON
All (%) Colon cancer (%) Rectal cancer (%) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI)
rs1902432 TT 0.557 170 (34.07) 160 (36.87) 90 (39.47) 70 (33.98) 1 (Ref) 1 (Ref)
TC 237 (47.49) 208 (47.92) 111 (48.68) 97 (47.09) 0.830 0.97 (0.71–1.31) 0.638 0.92 (0.64–1.31) 0.874 1.03 (0.71–1.51)
CC 92 (18.44) 66 (15.21) 27 (11.85) 39 (18.93) 0.163 0.74 (0.49–1.13) 0.030 0.57 (0.33–0.94) 0.916 0.97 (0.59–1.60)
CC+TC vs TT 0.519 0.91 (0.6–1.22) 0.252 0.82 (0.58–1.15) 0.893 1.03 (0.72–1.47)
CC vs TT+TC 0.158 0.76 (0.53–1.11) 0.030 0.59 (0.36–0.95) 0.897 0.97 (0.63–1.51)
C vs T 0.229 0.89 (0.73–1.08) 0.051 0.79 (0.62–1.00) 0.970 1.01 (0.79–1.28)
rs4573233 GG 0.688 331 (66.73) 274 (63.57) 141 (61.84) 133 (65.52) 1 (Ref) 1 (Ref)
GA 150 (30.24) 138 (32.02) 77 (33.77) 61 (30.05) 0.615 1.08 (0.80–1.47) 0.394 1.17 (0.82–1.67) 0.947 0.99 (0.68–1.44)
AA 15 (3.03) 19 (4.41) 10 (4.39) 9 (4.93) 0.273 1.54 (0.71–3.32) 0.333 1.55 (0.64–3.76) 0.365 1.53 (0.61–3.80)
AA+GA vs GG 0.442 1.12 (0.84–1.50) 0.297 1.20 (0.85–1.69) 0.850 1.04 (0.72–1.49)
AA vs GG+GA 0.294 1.50 (0.71–3.18) 0.400 1.46 (0.61–3.48) 0.344 1.54 (0.63–3.78)
A vs G 0.312 1.14 (0.89–1.46) 0.243 1.19 (0.89–1.60) 0.631 1.08 (0.79–1.47)
rs710885 TT 0.122 446 (88.32) 370 (85.65) 195 (85.53) 175 (85.78) 1 (Ref) 1 (Ref)
TG 55 (10.89) 57 (13.19) 32 (14.04) 25 (12.25) 0.090 1.45 (0.94–2.21) 0.100 1.51 (0.92–2.48) 0.250 1.37 (0.80–2.32)
GG 4 (0.79) 5 (1.16) 1 (0.43) 4 (1.97) 0.506 1.62 (0.39–6.76) 0.673 0.62 (0.06–5.88) 0.176 2.84 (0.63–12.93)
GG+TG vs TT 0.072 1.46 (0.97–2.21) 0.133 1.45 (0.89–2.35) 0.132 1.48 (0.89–2.45)
GG vs TT+TG 0.543 1.56 (0.37–6.54) 0.647 0.59 (0.06–5.65) 0.193 2.74 (0.60–12.51)
G vs T 0.065 1.44 (0.98–2.11) 0.192 1.35 (0.86–2.14) 0.071 1.53 (0.96–2.44)
rs785005 GG 0.629 221 (44.92) 199 (45.96) 97 (42.73) 102 (49.51) 1 (Ref) 1 (Ref)
GA 221 (44.92) 190 (43.88) 102 (44.94) 88 (42.72) 0.579 0.92 (0.68–1.24) 0.982 1.00 (0.70–1.43) 0.334 0.84 (0.58–1.20)
AA 50 (10.16) 44 (10.16) 28 (12.33) 16 (7.77) 0.763 0.93 (0.57–1.52) 0.509 1.21 (0.69–2.11) 0.198 0.65 (0.34–1.25)
AA+GA vs GG 0.570 0.92 (0.70–1.22) 0.808 1.04 (0.75–1.46) 0.216 0.80 (0.57–1.14)
AA vs GG+GA 0.896 0.97 (0.61–1.54) 0.474 1.21 (0.71–2.04) 0.292 0.72 (0.39–1.33)
A vs G 0.627 0.95 (0.77–1.17) 0.607 1.07 (0.83–1.37) 0.159 0.83 (0.64–1.08)
rs2632159 TT 0.991 357 (70.55) 281 (65.20) 142 (62.83) 139 (67.81) 1 (Ref) 1 (Ref)
TC 136 (26.88) 130 (30.16) 77 (34.07) 53 (25.85) 0.129 1.27 (0.93–1.73) 0.033 1.48 (1.03–2.12) 0.789 1.06 (0.71–1.56)
CC 13 (2.57) 20 (4.64) 7 (3.10) 13 (6.34) 0.026 2.38 (1.11–5.09) 0.304 1.67 (0.63–4.41) 0.008 3.12 (1.34–7.23)
CC+TC vs TT 0.040 1.37 (1.01–1.84) 0.022 1.51 (1.06–2.14) 0.286 1.22 (0.85–1.77)
CC vs TT+TC 0.041 2.19 (1.03–4.64) 0.445 1.46 (0.56–3.81) 0.009 3.03 (1.32–6.94)
C vs T 0.013 1.39 (1.07–1.79) 0.023 1.42 (1.05–1.92) 0.061 1.35 (0.99–1.85)

Terms in bold represent significant results (P<0.05). PHWE = P value for Hardy–Weinberg Equilibrium.Abbreviations: CRC, colorectal cancer; NA, not available. *, the sort order was according to the SNP location in its genes from 5′ starting to 3′ ends. , P value was calculated by adjusted age and gender.